ANTI-FOLATE RESISTANCE IN LEUKEMIA - TREATMENT WITH HIGH-DOSE METHOTREXATE AND CITROVORUM FACTOR

被引:26
作者
BENDER, RA
机构
[1] NCI,MED BRANCH,BETHESDA,MD 20014
[2] NCI,LAB CHEM PHARMACOL,BLDG 10,ROOM 12N226,BETHESDA,MD 20014
关键词
D O I
10.1016/S0305-7372(75)80004-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:215 / 224
页数:10
相关论文
共 58 条
[11]  
DJERASSI I, 1967, CANCER, V20, P233, DOI 10.1002/1097-0142(1967)20:2<233::AID-CNCR2820200209>3.0.CO
[12]  
2-8
[13]  
DJERASSI I, 1972, CANCER, V30, P22, DOI 10.1002/1097-0142(197207)30:1<22::AID-CNCR2820300105>3.0.CO
[14]  
2-B
[15]   PERTURBATION OF GENERATION CYCLE OF HUMAN LEUKEMIC MYELOBLASTS IN-VIVO BY METHOTREXATE [J].
ERNST, P ;
KILLMANN, SA .
BLOOD-THE JOURNAL OF HEMATOLOGY, 1971, 38 (06) :689-&
[16]  
ERNST P, 1969, ACTA MED SCAND, V186, P239
[17]   TEMPORARY REMISSIONS IN ACUTE LEUKEMIA IN CHILDREN PRODUCED BY FOLIC ACID ANTAGONIST, 4-AMINOPTEROYL-GLUTAMIC ACID (AMINOPTERIN) [J].
FARBER, S ;
DIAMOND, LK ;
MERCER, RD ;
SYLVESTER, RF ;
WOLFF, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1948, 238 (23) :787-793
[18]  
FYFE MJ, 1973, J BIOL CHEM, V248, P5067
[19]  
GOLDMAN ID, 1968, J BIOL CHEM, V243, P5007
[20]  
GOLDMAN ID, 1974, MOL PHARMACOL, V10, P257